Navigation Links
Cure for cancer one step closer

The cure for cancer is one step closer this week with the first collections of cancer tissue taking place at the new Wesley Research Institute Tissue Bank.

The Tissue Bank is the first of its kind in Queensland to provide a widely available and diversified collection of ethically consented and clinically annotated tissue, helping to unravel the cause, progression and potential treatment for cancer and other diseases.

Professor Julie Campbell AO, Director of The Wesley Research Institute, said the current absence of large, high quality cancer tissue and blood collections with clinical data is a major barrier to improving care of cancer patients.

"Queensland research has taken an enormous step forward this week. There is every possibility that findings made achievable by the Tissue Bank will lead to the next big breakthrough in the fight against cancer," she said.

"By providing researchers who are part of an ethically and scientifically approved research project with tissue, matching blood samples and full clinical data, valuable funds will be saved, which can then be applied to further their research.

"There is compelling evidence that new methods for screening, diagnosis and evaluation of cancer can make a significant impact on cancer care in the immediate future," Professor Campbell said.

Dr John Lumley, a surgeon from The Wesley Hospital, said that these specimens would be donated by consenting patients during the course of their normal treatment.

"I encourage patients and surgeons to support the important work of the Tissue Bank because everybody can play a part in the cure. Every cell contains a clue that can make a difference to tomorrow's cancer patients," he said.

Queensland is well placed as a source of cancer tissue due to its diverse population, large number of aged retirees, and high-rate of some cancers, particularly melanoma. The Wesley Hospital alone had almost 2000 cancer rel
'"/>

Source:Research Australia


Page: 1 2

Related biology news :

1. Viral DNA sequence a possible trigger for breast cancer
2. Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer
3. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
4. Columbia research lifts major hurdle to gene therapy for cancer
5. Combination therapy boosts effectiveness of telomere-directed cancer cell death
6. Mitochondrial DNA mutations play significant role in prostate cancer
7. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
8. BRCA1 causes ovarian cancer through indirect, biochemical route
9. Researchers identify target for cancer drugs
10. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
11. First atlas of key brain genes could speed research on cancer, neurological diseases

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cure for cancer one step closer

(Date:12/3/2009)...olar panels that repels grime and dirt? Expanded b...r? New Tel Aviv University research, just publishe...gh in assembling peptides at the nano-scale level ... in just a few years. , Operating in the range o...) and even smaller, graduate student Lihi Adler-Ab...
(Date:12/3/2009)... a personality change in warmer water, according t...change may make some species more aggressive. , ...n Australia,s Great Barrier Reef have shown for th...tently timid, or consistently bold, and that these...ter temperatures rise. , A slight lift of just o...
(Date:12/3/2009)...ists from the U.S. Department of Energy,s (DOE) Br...and the Indian Institute of Science has made a maj...genetic information in DNA that is necessary to ca...ch, published in the December 1, 2009 edition of ...hat many proteins responsible for interacting at s...
Breaking Biology News(10 mins):A window that washes itself? 2Fish with attitude: Some like it hot 2Grooving down the helix 2Grooving down the helix 3Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease 4733 1Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease 4733 2Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease 4733 3Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease 4733 4Long Term Care 3A The Next Big Womens Issue 3F 51873 1Long Term Care 3A The Next Big Womens Issue 3F 51873 2Sinovac Adjourns 2008 Annual General Meeting 13056 1Sinovac Adjourns 2008 Annual General Meeting 13056 2
... The General Services Administration (GSA) has cer... a provider of Personal Identity Verification (PIV...managed services, under Homeland Security Presiden...on, ABBTECH will offer services through their GSA ...n approved service provider. Services provided b...
...l 3, 2009 -- By identifying a novel compound that ... Ridge National Laboratory and the University of C...stant plants. , In a paper published in Science ...artment of Energy,s ORNL reports that azelaic acid...abidopsis, a small flowering plant related to cabb...
...itor of Playboy magazine, has won the 2009 Media A...ces (AIBS), given to a journalist for outstanding ...r broadcast journalism. Rowe,s story, "Sexual Male... the magazine on scientists, findings during the p...lopment. This segment of the series appeared in th...
Other Biology News:ABBTECH Staffing Services Certified by GSA as an HSPD-12 Managed Service Provider 2Researchers discover primer to plant defense system 22009 AIBS Media Award 22009 AIBS Media Award 3
(Date:12/2/2009)...AI, Dec. 2 /PRNewswire-Asia/ -- The world is going...il and uncertainty is part of many,businesses and ...has been,relatively immune to the economic downtur... During the midst of the difficult times this ...on inaugurated an R&D center in Shanghai, the ...
(Date:12/1/2009)... Dr. Kerry Solomon announced that he has joined Ca...esigned website at www.DrKerrySolomon.com , which...olomon is a proven LASIK, lens implant, and catara...gnized for his substantial contributions to improv...Trusted LASIK Surgeons, which screens LASIK surgeo...
(Date:12/1/2009)...K, Dec. 1 Reportlinker.com announc...in its catalogue: ,, Industrial Enzymes - A Gl....com/p0164431/Industrial-Enzymes---A-Global-Market...n oligopoly with few strong players and a host of .... Keen competition and commoditization characteriz...
(Date:12/1/2009)...DGE, Mass., Dec. 1 To address the ... promote its potential, a group of individuals and...c Biology Industry Association (SynBIA) in Cambrid...iation is to provide a forum for individuals and c...ddress its opportunities and its challenges, and a...
Breaking Biology Technology:Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2
...sdaq: FOLD ) will announce third quarter 2008 fin...on Monday, November 3, 2008. The results,announcem... webcast that,afternoon at 5 p.m. ET., Interested...nce call at,5 p.m. ET by dialing 877-419-6591 (U.S...honic replay of the call will be available for,sev...
...Eastern Time Today to D...st,Pharmaceuticals, Inc. (Nasdaq: BCRX ) today an... intravenous (i.v.) peramivir, a neuraminidase,inh... or potentially,life-threatening influenza. The Ph...ve days of therapy with either 200 mg i.v. peramiv...
...tivities, enhancement in research investment from ...of user-friendly products is likely to propel the ...tic and manual, to reach $315 million by 2015. , ...B) October 27, 2008 -- Titration is one of the mos...he chemical composition of laboratory and industri...
Other Biology Technology:Amicus Therapeutics Announces Third Quarter 2008 Results Release Date 2BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza 2BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza 3BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza 4BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza 5BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza 6Titrators Market to Reach $315 Million by 2015, According to New Report by Global Industry Analysts, Inc. 2Titrators Market to Reach $315 Million by 2015, According to New Report by Global Industry Analysts, Inc. 3
...98C679.2.1] to Presenilin 2 Alzheimer's disease (... carry mutations in the presenilin proteins (PSEN1...hese disease-linked mutations result in increased ...n component of amyloid deposits found in AD brains...
CryoPlus Square Rack, CP-13-2-CW/100, 27-11/32" OAH from Thermo Scientific
Goat Anti-Human Glypican 2 Polyclonal Antibody, Biotin Conjugated from R&D Systems
Beta 2-Microglobulin ELISA Kit from Biomeda Corporation
Biology Products: